Similar articles

• Antibody engineering.

  Maynard J, Georgiou G. Maynard J, et al. Annu Rev Biomed Eng. 2000;2:339-76. doi: 10.1146/annurev.bioeng.2.1.339. Annu Rev Biomed Eng. 2000. PMID: 11701516 Review.
• Antibody evolution beyond Nature.

  Borrebaeck CA, Ohlin M. Borrebaeck CA, et al. Nat Biotechnol. 2002 Dec;20(12):1189-90. doi: 10.1038/nbt1202-1189. Nat Biotechnol. 2002. PMID: 12454662 No abstract available.
• Antibody engineering.

  Dall'Acqua W, Carter P. Dall'Acqua W, et al. Curr Opin Struct Biol. 1998 Aug;8(4):443-50. doi: 10.1016/s0959-440x(98)80121-8. Curr Opin Struct Biol. 1998. PMID: 9729735 Review.
• Mono- and bivalent antibody fragments produced in Escherichia coli: engineering, folding and antigen binding.

  Plückthun A. Plückthun A. Immunol Rev. 1992 Dec;130:151-88. doi: 10.1111/j.1600-065x.1992.tb01525.x. Immunol Rev. 1992. PMID: 1286869 No abstract available.
• Therapeutic antibodies and antibody fusion proteins.

  Rohrbach P, Broders O, Toleikis L, Dübel S. Rohrbach P, et al. Biotechnol Genet Eng Rev. 2003;20:137-63. doi: 10.1080/02648725.2003.10648041. Biotechnol Genet Eng Rev. 2003. PMID: 14997850 Review. No abstract available.